BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32792224)

  • 1. Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy.
    Sayan M; Vergalasova I; Jhawar S; Kumar S; George M; Kowzun M; Potdevin L; Toppmeyer D; Haffty B; Ohri N
    Clin Breast Cancer; 2021 Feb; 21(1):31-36. PubMed ID: 32792224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis.
    Rice SR; Feigenberg SJ; Hamza M; Molitoris JK; Bentzen SM; Tkaczuk KHR; Rosenblatt PM; Bellavance EC; Nichols EM
    Breast Cancer Res Treat; 2019 Jun; 175(2):473-478. PubMed ID: 30796656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
    Herskovic AC; Wu X; Christos PJ; Nagar H
    Clin Breast Cancer; 2018 Oct; 18(5):418-431. PubMed ID: 29530585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends and Patterns of Utilization of Hypofractionated Postmastectomy Radiotherapy: A National Cancer Database Analysis.
    Venigalla S; Guttmann DM; Jain V; Sharma S; Freedman GM; Shabason JE
    Clin Breast Cancer; 2018 Oct; 18(5):e899-e908. PubMed ID: 29550285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on Accelerated Whole Breast Irradiation.
    Shah C; Fleming-Hall E; Asha W
    Clin Breast Cancer; 2023 Apr; 23(3):237-240. PubMed ID: 36792457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients.
    Sayan M; Abou Yehia Z; Gupta A; Toppmeyer D; Ohri N; Haffty BG
    Front Oncol; 2019; 9():970. PubMed ID: 31632906
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.
    Bekelman JE; Sylwestrzak G; Barron J; Liu J; Epstein AJ; Freedman G; Malin J; Emanuel EJ
    JAMA; 2014 Dec; 312(23):2542-50. PubMed ID: 25494006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Outcomes of Post-mastectomy Breast Cancer Patients Treated with Hypofractionated Radiation Treatment Compared to Conventional Fractionation -a Retrospective Cohort Study.
    Raveendran C; Meloot SS; Yadev I
    Gulf J Oncolog; 2023 May; 1(42):26-34. PubMed ID: 37283257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
    Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
    Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study.
    Pinnarò P; Giordano C; Farneti A; Faiella A; Iaccarino G; Landoni V; Giannarelli D; Vici P; Strigari L; Sanguineti G
    J Exp Clin Cancer Res; 2017 Dec; 36(1):191. PubMed ID: 29282078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
    Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
    Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation therapy utilization and outcomes for older women with breast cancer: Impact of molecular subtype and tumor grade.
    Haque W; Kee Yuan DM; Verma V; Butler EB; Teh BS; Wiederhold L; Hatch S
    Breast; 2017 Oct; 35():34-41. PubMed ID: 28646722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
    Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    Bingham B; Patel CG; Shinohara ET; Attia A
    J Neurooncol; 2018 Jan; 136(2):385-394. PubMed ID: 29209874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
    De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of hypofractionated radiotherapy with concurrent anti-HER-2 therapy following breast-conserving therapy for breast cancer.
    Dreyfuss AD; Barsky AR; Taunk NK; Clark AS; Freedman GM
    Breast J; 2019 Nov; 25(6):1097-1103. PubMed ID: 31254304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
    Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
    Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial.
    Offersen BV; Alsner J; Nielsen HM; Jakobsen EH; Nielsen MH; Krause M; Stenbygaard L; Mjaaland I; Schreiber A; Kasti UM; Overgaard J;
    J Clin Oncol; 2020 Nov; 38(31):3615-3625. PubMed ID: 32910709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has Hypofractionated Whole-Breast Radiation Therapy Become the Standard of Care in the United States? An Updated Report from National Cancer Database.
    Kang MM; Hasan Y; Waller J; Saulsberry L; Huo D
    Clin Breast Cancer; 2022 Jan; 22(1):e8-e20. PubMed ID: 34257001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
    Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
    Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.